Skip to Content

Pfizer STN 12.5 mg (Sutent 12.5 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 12.5 mg is Orange, Capsule-shape and has been identified as Sutent 12.5 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 12.5 mg

Sutent

Generic Name
sunitinib
Imprint
Pfizer STN 12.5 mg
Strength
12.5 mg
Color
Orange
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC)
00069-0550
Inactive Ingredients
mannitol, croscarmellose sodium, povidone k25, magnesium stearate, titanium dioxide, ferric oxide red, shellac, propylene glycol, sodium hydroxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.